0001179110-22-001332.txt : 20220216 0001179110-22-001332.hdr.sgml : 20220216 20220216164017 ACCESSION NUMBER: 0001179110-22-001332 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220214 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williamson Douglas J CENTRAL INDEX KEY: 0001911501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 22644150 MAIL ADDRESS: STREET 1: AVADEL PHARMACEUTICALS PLC STREET 2: 10 EARLSFORT TERRACE CITY: DUBLIN STATE: L2 ZIP: D02 T390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 edgar.xml FORM 4 - X0306 4 2022-02-14 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001911501 Williamson Douglas J C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 6.6 2022-02-14 4 A 0 275000 0 A 2032-02-14 ADSs 275000 275000 D Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. /s/ Jerad G. Seurer, as Attorney-in-Fact 2022-02-16